Aridis Pharmaceuticals
Stock Forecast, Prediction & Price Target
Aridis Pharmaceuticals Financial Estimates
Aridis Pharmaceuticals Revenue Estimates
Aridis Pharmaceuticals EBITDA Estimates
Aridis Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $1M N/A | $0 -100% | $0 0% | Avg: $75.92M Low: $75.92M High: $75.92M avg. 0% | |||
Net Income
% change YoY
| $-21.91M N/A | $-42.28M -92.89% | $-30.74M 27.27% | Avg: $27.60M Low: $27.60M High: $27.60M avg. 189.76% | |||
EBITDA
% change YoY
| $-22.06M N/A | $-44.43M -101.38% | $-29.50M 33.59% | Avg: $-15.18M Low: $-15.18M High: $-15.18M avg. 48.53% | |||
EPS
% change YoY
| -$2.39 N/A | -$3.44 -43.93% | -$1.64 52.32% | Avg: $1.47 Low: $1.47 High: $1.47 avg. 189.63% | |||
Operating Expenses
% change YoY
| $23.40M N/A | $43.71M 86.79% | $29.99M -31.38% | Avg: $239.10M Low: $239.10M High: $239.10M avg. 697.18% | |||
FAQ
What is Aridis Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 189.76% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is 27.60M, average is 27.60M and high is 27.60M.
What is Aridis Pharmaceuticals stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is $75.92M, average is $75.92M and high is $75.92M.
What is Aridis Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 189.63% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is $1.47, average is $1.47 and high is $1.47.